US’s biotech scrutiny tests China’s drugmakers abroad
Add ThinkChina as a preferred source Attendees look at the China booth at the BIO International Convention 2026, a meeting of pharmaceutical and biotechnology leaders in San Diego, California, US, on 23 June 2026. (Mike Blake/Reuters) (By Caixin journalist Chen Xi) US lawmakers’ push to scrutinise biotechnology ties with China is unsettling expectations for Chinese…